AzTrials
AzTrials

Bone ResorptionNCT03052387

Vertical Augmentation Using Onlay Versus Inlay Autogenous Graft With Simultaneous Implant Placement.

A study testing assigned intervention in people with Bone Resorption, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Using autogenous Chin block for vertical augmentation with simultaneous implant placement at anterior maxilla region comparing between the Onlay and Inlay grafting techniques. Read more about this study

Who is it for?
Ages 21 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Bone Resorption
What is being tested?
assigned intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
12 participants
Where
No sites listed yet
Study dates
Mar 2017to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • * Patients with partially edentulous anterior maxillary ridges.
  • Patients were free from any systemic disease that interferes with bone healing.
  • Absence of local pathosis at anterior maxillary area.
  • No history of any grafting procedure at the designated edentulous ridge.
  • The edentulous ridge vertical dimension was less than 10 mm measured from the alveolar crest to the nasal floor (i.e.ridge had vertical inadequacy) with normal horizontal alveolar dimension or patient with Increased Inter-Arch Space.

Who cannot join

  • * Patient with fully dentulous maxilla.
  • Pregnant females.
  • Presence of bad habits (severe bruxism, clenching).
  • Systemic diseases that may interfere with bone healing.e.g. uncontrolled Diabetes.

About this study

Official title: Assessment of Vertical Bone Augmentation Using Autogenous Onlay Versus Inlay Grafting Techniques With Simultaneous Implant Placement in the Anterior Maxillary Area on Patient's Esthetic Satisfaction : A Randomized Clinical Trial

Using autogenous Chin block for vertical augmentation with simultaneous implant placement at anterior maxilla region comparing between the Onlay and Inlay grafting techniques.

Read the detailed description

to study the vertical augmentation with simultaneous implant placement at anterior maxillary region.

  • P: Patient requires implant at anterior maxillary ridge with vertical deficiency.
  • I:Inlay Sandwich Technique with immediate implant placement.
  • C:Onlay autogenous graft immediate implant placement.
  • O:Outcome name Measuring device Measuring unit

Primary outcome: Vertical bone gain CBCT Millimeter

-Secondary outcome(a): Crestal bone loss CBCT Millimeter

Conditions
Bone Resorption
Being tested
assigned intervention
Medical subject headings
Bone Resorption

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • assigned interventionOther

    • Local anesthesia with vasoconstrictor(V.C) used for hemostasis. chin block graft
    • Scrubbing and draping of the patient will be carried out in a standard fashion using betadine surgical scrub.
    • The donor site is usually the chin area, its approached using local anesthesia with VC at symphysis region.
    • Low vestibular incision exposing the symphysis area to the inferior border of the mandible.
    • Using fissure bur to harvest the graft for the defect.
    • Closure using vicryl 3-O sutures.
Study groups in NCT03052387
Study groupRoleWhat they receive
controlPlacebo comparator* Crestal pyramidal flap will be done with 2 releasing incisions for adequate exposure. * Buccal\& palatal full reflection for adequate exposure and to avoid the interference between the onlay graft and the residual bone. * Decortication of the bone bed to increase the blood supply to the onlay graft. * The block graft harvested from the chin is placed crestal to the residual ridge and stabilized in place using dental implant immediately. * Periosteal incisions are usually needed to allow tension free sutures. * Vicryl 3/0 sutures for closer. * augmentin 1g twice daily for 5 days. * catflam 50g twice daily for 3 days
Receives: Other: assigned intervention
ComparatorActive comparator* Crestal incision with labial flap reflected leaving the palatal tissues without elevation. * Marking of the 3 bony cuts ( 2 vertical cuts \& 1 horizontal cut ) using fine fissure bur in the form of perforations along the cuts position. * Drilling of pilot drill and first drill only. * 3 full thickness cuts will be performed (2 vertical stop cuts will be made by using the tungsten carbide disc at the distal ends of the horizontal bony cut on the facial surface of alveolar ridge. * splitting osteotomes are used and mallet to complete the splitting of the bony segment. * After bony separation the rectangular bony segment (transport segment) will be mobilized occlusally and pedicled on the palatal mucoperiosteum. * The autogenous block graft harvested from the chin area is placed in the space gained under the mobile bony segment. * Drilling through the bony segment and the block graft. * Immediate implant placement chin graft block dental implants
Receives: Other: assigned intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. vertical Bone gain

    • The nasal floor will be used as a fixed reference by adjusting the cross sectional long axis in the center of the area of interest and bisecting it (showing the buccolingual dimension).
    • All the patients will wear the radiographic dentures with radiopaque material (barium sulphate mixed with acrylic powder) filling the teeth at the area of interest to ensure that the calculations were taken at the same region.
    • On the cross sectional view of CBCT and at each proposed implant site, a line will be drawn starting from the crest of the ridge till the nasal floor. The height will be recorded preoperatively, immediately (1 week) and 6 months postoperatively.the difference between them in millimeters will be recorded.

    Measured: 6 months

Secondary outcomes (1)
  1. crestal bone loss

    crestal bone loss around the implant will be measured in millimeter after 6 months

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2017
  2. Study startMar 2017 (estimated)
  3. Primary completionAug 2017 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03052387
Sponsor's protocol ID
CairoAMI-CG
Status last verified
Feb 2017
First submitted
7 Feb 2017
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: assessment of vertical ridge augmentation using autogenous Onlay versus Inlay Bone Grafting techniques in the anterior maxilla.

Questions about this trial

What is this clinical trial studying?

A study testing assigned intervention in people with Bone Resorption, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

vertical Bone gain (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in